Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Amicus Therapeutics Inc.

    NASDAQ: FOLD · Real-Time Price · USD
    5.78
    -0.15 (-2.53%)
    At close: Jun 30, 2025, 11:33 AM

    Amicus Therapeutics Revenue

    Amicus Therapeutics reported an annual revenue of $528.29M, reflecting a 32.29% growth. For the quarter ending March 31, 2025, Amicus Therapeutics generated $125.25M in revenue.
    Revenue (ttm)
    $528.29M
    Revenue Growth
    32.29%
    Price / Sales Ratio
    5.43
    Revenue / Employee
    $1.06M
    Employees
    499
    Market Cap
    1.78B

    Revenue Chart

    Revenue History

    Fiscal Year End Revenue % Change
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist